Radial Shockwave for Spasticity in Children With CP or ABI
NCT ID: NCT06909838
Last Updated: 2025-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2024-09-24
2025-06-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Is it feasible to implement radial shockwave therapy in conventional physiotherapy plan in children with CP or TBI?
* Is it safe and effective to use rESWT for reducing spasticity in children with CP or TBI? Participants will receive a 4 week therapy intervention, as add on to the conventional physio (usual care), including one rESWT session per week for a total of 4 sessions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Shock Wave Therapy for Management of Spasticity in Patients With Cerebral Palsy
NCT05702606
Efficacy of Extracorporeal Shock Wave Therapy in Children With Cerebral Palsy
NCT06128616
Shock Wave and Spastic Cerebral Palsy Equines Foot
NCT04835753
Radial Extracorporeal Shock Wave Therapy for Spastic Plantar Flexor Muscles in Young Children With Cerebral Palsy
NCT02719483
Effect of Session Frequency of rESWT on Gastrocnemius Muscle Spasticity in Children With Spastic Type Cerebral Palsy
NCT04574622
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual care
Conventional physiotherapy plan
Conventional treatment
Usual conventional therapy, including physiotherapy, ergotherapy, hippotherapy,..
Shockwave and usual care
All participants receive a 4-week rESWT intervention plan (4 sessions with a one week interval), as add-on to the conventional physiotherapy plan
radial Extracorporeal shockwave therapy (rESWT)
4 rESWT interventions, with a one week interval, are added to the conventional treatment plan
Conventional treatment
Usual conventional therapy, including physiotherapy, ergotherapy, hippotherapy,..
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
radial Extracorporeal shockwave therapy (rESWT)
4 rESWT interventions, with a one week interval, are added to the conventional treatment plan
Conventional treatment
Usual conventional therapy, including physiotherapy, ergotherapy, hippotherapy,..
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* between 6-18 years old;
* gross motor function classification ≥2;
* experiencing spasticity in the lower limb (calf muscles, hip adductor muscles or hamstring muscles) and/or in the upper limb (biceps muscle, wrist flexor muscles, finger flexor muscles) with Modified Ashworth Scores (MAS) ≥1+.
Exclusion Criteria
* local infections or wounds; neuropathy;
* severe organ dysfunction;
* severe psychosocial dysfunction that would not allow adhering to protocol;
* planned changes in medication dosage or medication scheme that might affect spasticity during a 4-month intervention and follow-up phase.
6 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
FRAME Jessa Ziekenhuis, Belgium
UNKNOWN
Gymna Uniphy
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Aerssens, Pediatrician
Role: PRINCIPAL_INVESTIGATOR
MFC Sint Gerardus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sint-Gerardus
Diepenbeek, Limburg, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S68824
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.